Yan D - Search Results

1

Reduced expression of PER3 is associated with incidence and development of colon cancer.

Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun X, Li T, Xing T, Tang H, Peng X, Peng Z. Wang X, et al. Among authors: yan d. Ann Surg Oncol. 2012 Sep;19(9):3081-8. doi: 10.1245/s10434-012-2279-5. Epub 2012 Feb 17. Ann Surg Oncol. 2012. PMID: 22350604

2

Screening of tumor suppressor genes on 1q31.1-32.1 in Chinese patients with sporadic colorectal cancer.

Zhou CZ, Qiu GQ, Wang XL, Fan JW, Tang HM, Sun YH, Wang Q, Huang F, Yan DW, Li DW, Peng ZH. Zhou CZ, et al. Chin Med J (Engl). 2008 Dec 20;121(24):2479-86. Chin Med J (Engl). 2008. PMID: 19187582

3

IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

Li D, Yan D, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z. Li D, et al. Among authors: yan d. Ann Surg Oncol. 2009 Dec;16(12):3499-506. doi: 10.1245/s10434-009-0648-5. Ann Surg Oncol. 2009. PMID: 19672661

4

Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.

Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH. Li DW, et al. J Cancer Res Clin Oncol. 2010 Jul;136(7):997-1006. doi: 10.1007/s00432-009-0745-7. Epub 2009 Dec 19. J Cancer Res Clin Oncol. 2010. PMID: 20024662

5

Upregulated INHBA expression is associated with poor survival in gastric cancer.

Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan DW, Tang HM, Peng ZH. Wang Q, et al. Med Oncol. 2012 Mar;29(1):77-83. doi: 10.1007/s12032-010-9766-y. Epub 2010 Dec 4. Med Oncol. 2012. PMID: 21132402

6

Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.

Fan J, Yan D, Teng M, Tang H, Zhou C, Wang X, Li D, Qiu G, Peng Z. Fan J, et al. Among authors: yan d. Clin Cancer Res. 2011 May 1;17(9):2908-18. doi: 10.1158/1078-0432.CCR-10-2552. Epub 2011 Jan 10. Clin Cancer Res. 2011. PMID: 21220475

7

Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma.

Sun HC, Li M, Lu JL, Yan DW, Zhou CZ, Fan JW, Qin XB, Tang HM, Peng ZH. Sun HC, et al. Oncol Rep. 2011 Jun;25(6):1533-9. doi: 10.3892/or.2011.1230. Epub 2011 Mar 22. Oncol Rep. 2011. PMID: 21431285

8

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.

Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z. Wen Y, et al. Among authors: yan d. Ann Surg Oncol. 2011 Dec;18(13):3858-67. doi: 10.1245/s10434-011-1668-5. Epub 2011 Mar 26. Ann Surg Oncol. 2011. PMID: 21442347

9

Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.

Li D, Peng X, Yan D, Tang H, Huang F, Yang Y, Peng Z. Li D, et al. Among authors: yan d. Ann Surg Oncol. 2011 Jul;18(7):2074-83. doi: 10.1245/s10434-011-1567-9. Epub 2011 Mar 26. Ann Surg Oncol. 2011. PMID: 21442350

10

FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria.

Sun H, Teng M, Liu J, Jin D, Wu J, Yan D, Fan J, Qin X, Tang H, Peng Z. Sun H, et al. Among authors: yan d. Cancer Lett. 2011 Jul 28;306(2):214-22. doi: 10.1016/j.canlet.2011.03.009. Epub 2011 Apr 11. Cancer Lett. 2011. PMID: 21482449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,955 results

Search Page

Filters